Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
Y. Watanabe, S. Fujisaka, Y. Morinaga, S. Watanabe, A. Nawaz, H. Hatta, T. Kado, A. Nishimura, M. Bilal, M. R. Aslam, K. Honda, Y. Nakagawa, S. Softic, K. Hirabayashi, T. Nakagawa, , K. Tobe
bioRxiv · Jun 21, 2023 · PreprintMicrobiology
K. Waki, H. Tani, E. Kawahara, Y. Saga, T. Shimada, E. Yamazaki, S. Koike, Y. Morinaga, M. Isobe, N. Kurosawa
This study shows that multimeric secretory IgA from nasal mucosa provides effective protection against SARS-CoV-2, even when monomeric IgA is non-neutralizing.
bioRxiv · Apr 10, 2023Immunology
E. Igarashi, T. Shimada, S. Yazawa, Y. Saga, M. Itamochi, N. Inasaki, Y. Morinaga, K. Oishi, H. Tani
This study examines how trypsin-like proteases affect SARS-CoV-2 infectivity in clinical specimens, finding significant increases for the delta variant compared to omicron.
bioRxiv · Sep 27, 2022 · PreprintMicrobiology
H. Yamada, S. Sasaki, H. Tani, M. Somekawa, H. Kawasuji, Y. Saga, Y. Yoshida, Y. Yamamoto, Y. Hayakawa, Y. Morinaga
This paper develops a hamster model of SARS-CoV-2 infection using a pseudotyped virus, showing dose-dependent luminescence in the lungs.
bioRxiv · Sep 17, 2021Microbiology
H. Tani, L. Tan, M. Kimura, Y. Yoshida, H. Yamada, S. Fukushi, M. Saijo, H. Kawasuji, A. Ueno, Y. Miyajima, Y. Fukui, I. Sakamaki, Y. Yamamoto, Y. Morinaga
This study evaluates SARS-CoV-2 neutralizing antibodies using a pseudotyped virus assay and compares results with immunofluorescence assay findings.
bioRxiv · Aug 21, 2020Microbiology